top of page

New Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment in CLL

Tue, Nov 17

|

Webinar

Registration is Closed
See other events
New Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment in CLL
New Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment in CLL

Time & Location

Nov 17, 2020, 6:00 PM

Webinar

About The Event

Tuesday, November 17, 2020, 6:00 PM ET

Thomas LeBlanc, MD, MA, MSH, FAAHPM Associate Professor, Division of Hematologic Malignancies and Cellular Therapy Department of Medicine, Duke University, Durham, NC

Nakhle Saba, MD Associate Professor of Medicine, Section of Hematology and Medical Oncology Tulane University, New Orleans, LA

REGISTER via link below:

https:// abbvie.meintl.com/00071-OB22-20

DURING THIS INTERACTIVE PROGRAM WE WILL:

Share This Event

BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page